Funding science is actually a badass thing to do
OR: The Three Sirens of Entropy| www.experimental-history.com
OR: The Three Sirens of Entropy| www.experimental-history.com
"It's a delicate exercise when you're dealing with a monopolist"| www.statecraft.pub
A GPT-3-like AI model for science would accelerate innovation and improve reproducibility. Creating it will require us to unlock research.| Future
I was inspired recently by an offhand joke from Jordan Dworkin that a major new cause area for the progress community could be metaparascience — the science of parascience.| www.macroscience.org
The U.S. Alzheimer’s Association provides critically important support services, education, programs, and referral services to countless individuals living with dementia, their families, and care professionals. It is making a real and meaningful difference in the lives of these people. However, over the years, the association engaged in a series of unhelpful and harmful activities for […]| ChangingAging
Scientific research today is afflicted by poor reliability and low utility, despite the best efforts of individual researchers.| worksinprogress.co
People who say “science is political” usually aren’t just stating facts - they’re trying to push something on you. Don’t let them| www.sciencefictions.org
We intend to improve incentives in science by developing smart research contracts.| atoms.org
A poem about the Alzheimer's drug Aduhelm and Medicare's upcoming (April 11 2022) final coverage decision| ChangingAging
* A reflection on STAT article: Joseph, A. (June 16, 2021). Q&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm – and why critics should stop dwelling on the decision. Link: https://www.statnews.com/2021/06/16/qa-ceo-alzheimers-association-on-aduhelm/ A lot has been said and written in recent weeks about the FDA controversial approval of the drug Aduhelm and the […]| ChangingAging
Introduction In 2006, the National Institutes of Health Reform Act passed Congress. 1 This droll, political document established a Scientific Management Review Board within the NIH. That board — comprised of Dr. Anthony Fauci, a former Lockheed Martin CEO and high-ranking NIH officials — was tasked with issuing recommendations for NIH reform; a noble and useful purpose. The board has not held a meeting since July 2015 and has written just eight reports in total, all of them between …| New Science
